Perigon Wealth Management, LLC Eli Lilly & CO Transaction History

Perigon Wealth Management, LLC

$3.67 Billion
Q3 2024

A detailed history of Perigon Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 38,548 shares of LLY stock, worth $28.8 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

38,548

Previous 39,222 1.72%

Holding current value

$28.8 Million

Previous $35.5 Million 3.83%

% of portfolio

0.93%

Previous 1.04%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$772.14 - $960.02 $520,422 - $647,053	-674 Reduced 1.72%	38,548 $34.2 Million
Q2 2024 Aug 02, 2024	BUY	$724.87 - $909.04 $185,566 - $232,714	256 Added 0.66%	39,222 $35.5 Million
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $1.2 Million - $1.61 Million	-2,028 Reduced 4.95%	38,966 $30.3 Million
Q4 2023 Jan 29, 2024	BUY	$525.19 - $619.13 $847,656 - $999,275	1,614 Added 4.1%	40,994 $23.9 Million
Q3 2023 Oct 30, 2023	BUY	$434.7 - $599.3 $158,665 - $218,744	365 Added 0.94%	39,380 $21.2 Million
Q2 2023 Aug 02, 2023	BUY	$350.74 - $468.98 $9.08 Million - $12.1 Million	25,875 Added 196.92%	39,015 $18.3 Million
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $310,940 - $365,184	1,001 Added 8.25%	13,140 $4.51 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $379,107 - $441,735	1,179 Added 10.76%	12,139 $4.44 Million
Q3 2022 Dec 13, 2022	SELL	$296.48 - $337.87 $5,929 - $6,757	-20 Reduced 0.18%	10,960 $3.54 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $508,960 - $597,595	1,826 Added 19.95%	10,980 $3.56 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $136,824 - $170,037	583 Added 6.8%	9,154 $2.62 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $196,968 - $244,439	876 Added 11.38%	8,571 $2.37 Million
Q3 2021 Nov 01, 2021	BUY	$221.6 - $272.71 $1.71 Million - $2.1 Million	7,695 New	7,695 $1.78 Million
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $1.77 Million - $2.18 Million	-7,978 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$180.55 - $233.54 $47,665 - $61,654	-264 Reduced 3.2%	7,978 $1.83 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $134,085 - $173,579	816 Added 10.99%	8,242 $1.54 Million
Q4 2020 Jan 28, 2021	BUY	$130.46 - $172.63 $51,401 - $68,016	394 Added 5.6%	7,426 $1.25 Million
Q3 2020 Nov 03, 2020	BUY	$146.22 - $169.13 $200,467 - $231,877	1,371 Added 24.22%	7,032 $1.04 Million
Q2 2020 Jul 29, 2020	BUY	$136.42 - $164.18 $126,324 - $152,030	926 Added 19.56%	5,661 $929,000
Q1 2020 Apr 17, 2020	BUY	$119.05 - $147.35 $249,885 - $309,287	2,099 Added 79.63%	4,735 $690,000
Q4 2019 Jan 13, 2020	BUY	$106.92 - $132.43 $19,031 - $23,572	178 Added 7.24%	2,636 $349,000
Q3 2019 Oct 25, 2019	SELL	$106.79 - $116.16 $64,501 - $70,160	-604 Reduced 19.73%	2,458 $270,000
Q2 2019 Aug 05, 2019	SELL	$110.79 - $129.32 $335,139 - $391,193	-3,025 Reduced 49.7%	3,062 $339,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $74,021 - $87,128	-665 Reduced 9.85%	6,087 $720,000
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $494,023 - $553,455	4,665 Added 223.53%	6,752 $776,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $179,189 - $223,955	2,087 New	2,087 $224,000
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $173,125 - $198,694	-2,287 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $5,565 - $6,570	-75 Reduced 3.18%	2,287 $177,000
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $327 - $351	-4 Reduced 0.17%	2,362 $199,000
Q3 2017 Dec 05, 2017	SELL	$77.07 - $85.54 $2.38 Million - $2.64 Million	-30,917 Reduced 92.89%	2,366 $202,000
Q2 2017 Sep 12, 2017	BUY	N/A	33,283 New	33,283 $2.74 Million
Q3 2011 Nov 14, 2022	SELL	N/A	-20	10,960 $3.54 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.

Account

Perigon Wealth Management, LLC Eli Lilly & CO Transaction History